Polycystic ovary syndrome (PCOS) in adolescents appears to present as two distinct subtypes based on the presence or absence of obesity, new data show. The findings support the “metabolic” and “reproductive” subtypes previously identified in adult women, say the researchers. Overall, PCOS affects 7% to 10% of adult women and is associated with significant metabolic …
Two Distinct Subtypes of PCOS Identified in Adolescents Read More »
The US Food and Drug Administration (FDA) has approved a supplemental indication for setmelanotide (Imcivree, Rhythm Pharmaceuticals) injection for chronic weight management in adults and pediatric patients age 6 and older with obesity due to Bardet-Biedl Syndrome (BBS). Setmelanotide, a melanocortin-4 receptor (MC4R) agonist, is the first FDA-approved therapy for BBS, a rare genetic disorder …
FDA Approves Setmelanotide for Obesity in Bardet-Biedl Syndrome Read More »
MADRID — During the International Scientific Symposium “New Frontiers in Scientific Research” that recently took place in Barcelona, specialists analyzed the role of the very-low-calorie ketogenic diet. This analysis was in relation to three comorbidities that have a higher incidence among overweight and obese patients: polycystic ovary syndrome, nonalcoholic fatty liver disease, and type 2 …
Can the Ketogenic Diet Treat Polycystic Ovary Syndrome? Read More »
People younger than 50 years with metabolic syndrome or obesity may need more effective prevention measures to help reduce their risk for colorectal cancer (CRC), new data suggest. Metabolic syndrome and obesity are positively linked with colorectal cancer before age 50, with rates similar to those in people diagnosed with CRC after age 50, reports …
People Under 50 With Obesity May Need More CRC Prevention Read More »
